Joint Replacement Segment, by Technique to Account Largest Joint Reconstruction Devices Market Share during 2025-2031

According to our new research study on "Joint Reconstruction Devices Market Forecast to 2031 - Global Analysis - by Type, Technique, and End User," the market was valued at US$ 28.06 billion in 2024 to US$ 39.87 billion by 2031; the market is expected to register a CAGR of 5.3% during 2025-2031. The joint reconstruction devices market growth is attributed to the rising aging population, advancements in biomaterials and surgical technologies, and escalating prevalence of lifestyle-induced musculoskeletal disorders.

The joint reconstruction devices market is driven by the increasing prevalence of lifestyle-induced musculoskeletal disorders, which are mainly a result of sedentary behaviors, obesity, and high-impact activities. These factors contribute to the wear and tear of the joints at a young age and across different demographics. The driver highlights the paradoxical effect of modern living: while long hours spent at the desk weaken the muscles that support the joints, at the same time, the increase in recreational sports leads to a higher number of injuries. In consequence, the demand for durable and adaptable reconstructive solutions is growing. For instance, the rising incidents of anterior cruciate ligament (ACL) tears among amateur soccer players have led to a higher demand for hybrid knee implants that not only combine metal alloys with ligament-augmenting scaffolds but also enhance the overall strength of the knee; in the UK, the Football Association's injury surveillance program 2023, reported that there have been 12,000 ACL injuries in non-professional leagues, out of which 25% have resulted in osteoarthritis causing a need for TKA within ten years.

Obesity also exacerbates the problem, as pointed out by the Centers for Disease Control, and Prevention (CDC) Vital Signs 2024 report which states that 42% of US adults are obese, and associates the condition with a 4-fold increase in knee replacement. The National Health Interview data from 2023 reveals that 7.5 million adults have reported severe joint pain, which has been the major cause for 800,000 arthroplasties performed annually. In Brazil, the Ministry of Health's SUS database 2024 shows metabolic syndrome as the reason behind a yearly hip reconstruction rate increase of 18% with 150,000 procedures in 2023. A good number of them are using modular stems for obese patients to facilitate load distribution, thus lowering the risk of periprosthetic fractures by 28%, as per a S